Drug Patent Watch
FEBRUARY 4, 2024
This chart shows the drugs with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
JAMA Internal Medicine
FEBRUARY 4, 2024
This randomized clinical trial evaluates whether testosterone replacement therapy prevents progression from prediabetes to diabetes or induces glycemic remission in middle-aged and older men with hypogonadism.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Commerce
FEBRUARY 4, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
JAMA Internal Medicine
FEBRUARY 4, 2024
This repeated cross-sectional study using difference-in-differences analyses assesses sleep duration changes in Black individuals after officer-involved killings of unarmed Black people.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
FEBRUARY 4, 2024
NATESTO (testosterone) Acerus Patent: 8,784,869 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit… The post Drug Patent Expirations for the Week of February 4, 2024 appeared first on DrugPatentWatch - Make Better Decisions.
FDA Law Blog
FEBRUARY 4, 2024
By Steven J. Gonzalez & Gail H. Javitt & Allyson B. Mullen — On January 18, 2024, the director of FDA’s Center for Devices and Radiological Health and the chief medical officer and acting director of CMS’ Center for Clinical Standards and Quality issued a joint press release supporting FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs).
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
FEBRUARY 4, 2024
The new company, BridgeBio Oncology Therapeutics, is looking to advance two KRAS inhibitors and a blocker of the interaction between the RAS and PI3K pathways.
BioSpace
FEBRUARY 4, 2024
Regeneron Pharmaceuticals on Thursday reported $1.4 billion in sales of its blockbuster eye drug in the first quarter of 2024, falling short of Wall Street’s expectations of $1.86 billion.
BioSpace
FEBRUARY 4, 2024
The Swiss drugmaker is paying $1 billion and committing up to $750 million in milestones for Mariana Oncology’s preclinical cancer pipeline and clinical supply capabilities, the companies announced Thursday.
BioSpace
FEBRUARY 4, 2024
Novo Nordisk on Thursday reported a jump in first-quarter 2024 revenue, driven by a more than 100% increase in sales of weight-loss drug Wegovy and the strong performance of type 2 diabetes medication Ozempic.
BioSpace
FEBRUARY 4, 2024
Astellas Pharma and Poseida Therapeutics have entered into a second CAR-T contract to develop novel and flexible allogeneic cell therapies in oncology.
BioSpace
FEBRUARY 4, 2024
Citing a strategic prioritization by Moderna, Metagenomi announced Wednesday that the partners have “mutually agreed” to terminate their gene editing agreement.
BioSpace
FEBRUARY 4, 2024
Boehringer Ingelheim on Wednesday won the FDA’s approval for a high-concentration and citrate-free version of its Humira biosimilar Cyltezo, targeting AbbVie’s blockbuster drug.
BioSpace
FEBRUARY 4, 2024
By incorporating soft skills in your resume, you showcase your ability to work well with others, which is important to employers.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
FEBRUARY 4, 2024
It’s important to quit your job the right way so you can exit on a positive note, which could benefit you in the future.
Expert insights. Personalized for you.
104 
Let's personalize your content